Aptevo Therapeutics Inc.
APVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671584
No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 9
- 13F valueReported value at the end of Q2 2026
- $224.3K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding APVO, Q2 2026
No superinvestor reported holding APVO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Aptevo Therapeutics Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | Grant Grady IIIDirector | PPurchase | +13.5K | $1.49 | +$20.1K | +1,351,300.0%13.5K after | |
| Jun 3, 2022 (view filing) | Jun 14, 2019 | 1,085 daysLate | Niederhuber JohnDirector | PPurchase | +714 | $0.91 | +$649.74 | +89.0%1.52K after | |
| Nov 26, 2021 (view filing)1:02 PM ET | Nov 23 | 3 days | Tang Kevin C and 2 othersOther: Exit Filing | SSale | −921.3K | $11.25 | −$10.4M | −100.0%0 after | 7 lots |
| Nov 22, 2021 (view filing)5:26 PM ET | Nov 18-22 | 4 days | Tang Kevin C and 2 others10% Owner | SSale | −838.7K | $7.75 | −$6.50M | −47.7%921.3K after | 10 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Aptevo Therapeutics Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gsa Capital Partners LLP | 21,539 | $96.0K | 0.01% | +1,901+9.7% | Added |
| Vanguard Capital Management LLC | 12,713 | $56.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,821 | $48.0K | 0.00% | −2,516−18.9% | Reduced |
| Vanguard Fiduciary Trust Co | 4,142 | $18.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 730 | $3.24K | 0.00% | −2,715−78.8% | Reduced |
| Advisor Group Holdings, Inc. | 360 | $1.60K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 109 | $484 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 31 | $138 | 0.00% | +31 | New |
| Danske Bank A/S | 1 | $4 | 0.00% | 00.0% | Unchanged |